Lantus® is a long-acting insulin analog indicated to improve glycemic control in adults and children (6 years and older) with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. Lantus® should be administered once a day at the same time every day. Important Limitations of Use: Lantus® is not recommended for the treatment of diabetic ketoacidosis. Use intravenous short-acting insulin instead. Lantus® SoloSTAR® is a disposable prefilled insulin pen.
| Website | http://www.lantus.com |
| Revenue | $22.7 million |
| Employees | View employees |
| Address | 1400 E Robur Dr, Sioux Falls, South Dakota 57104, US |
| Phone | +1 605-977-6470 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Johnson & Johnson, Merck & Co., Inc., Pfizer, Sanofi, Bayer, Novo Nordisk, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Lilly India +37 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Lantus employee's phone or email?
Lantus Questions
The Lantus annual revenue was $22.7 million in 2026.
Lantus is based in Sioux Falls, South Dakota.
The NAICS codes for Lantus are [32541, 32, 325, 3254].
The SIC codes for Lantus are [28, 283].
